These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21092049)

  • 1. Feasibility of implantable cardioverter defibrillator treatment in five patients with familial Friedreich's ataxia--a case series.
    Coskun KO; Popov AF; Schmitto JD; Coskun ST; Brandes I; Zenker D; Melnychenko I; Schoendube FA; Ruschewski W
    Artif Organs; 2010 Nov; 34(11):1061-5. PubMed ID: 21092049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
    Ng AC; Bertini M; Borleffs CJ; Delgado V; Boersma E; Piers SR; Thijssen J; Nucifora G; Shanks M; Ewe SH; Biffi M; van de Veire NR; Leung DY; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Dec; 106(11):1566-73. PubMed ID: 21094356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
    Yoda M; Tanabe H; Kishi M; Suma H
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.
    Kobza R; Jenni R; Erne P; Oechslin E; Duru F
    Pacing Clin Electrophysiol; 2008 Apr; 31(4):461-7. PubMed ID: 18373765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.